Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress
Go back to Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress| (NASDAQ: RVMD) | Delayed: 207.68 +0.36 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $207.32 | 52 Week High | $ | |||
| Open | $206.01 | 52 Week Low | $ | |||
| Day High | $213.00 | P/E | N/A | |||
| Day Low | $204.46 | EPS | $ | |||
| Volume | 1,227,158 | |||||

